Laboratory of Geroprotective and Radioprotective Technologies, Institute of Biology, Komi Science Center, Ural Branch, Russian Academy of Sciences, 167982 Syktyvkar, Russia.
Int J Mol Sci. 2023 Mar 22;24(6):6006. doi: 10.3390/ijms24066006.
The transcriptional coactivators Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) are the main downstream effectors of the evolutionarily conserved Hippo signaling pathway. YAP/TAZ are implicated in the transcriptional regulation of target genes that are involved in a wide range of key biological processes affecting tissue homeostasis and play dual roles in the aging process, depending on the cellular and tissue context. The aim of the present study was to investigate whether pharmacological inhibitors of Yap/Taz increase the lifespan of . Real-time qRT-PCR was performed to measure the changes in the expression of (, the homolog of YAP/TAZ) target genes. We have revealed a lifespan-increasing effect of YAP/TAZ inhibitors that was mostly associated with decreased expression levels of the and genes. However, further analysis is required to understand the link between the YAP/TAZ pathway and aging.
转录共激活因子 Yes 相关蛋白 (YAP) 和 PDZ 结合基序转录共激活因子 (TAZ) 是进化上保守的 Hippo 信号通路的主要下游效应物。YAP/TAZ 参与靶基因的转录调控,这些靶基因参与广泛的关键生物学过程,影响组织内稳态,并在衰老过程中发挥双重作用,具体取决于细胞和组织背景。本研究旨在探讨 Yap/Taz 的药理学抑制剂是否能延长 的寿命。通过实时 qRT-PCR 测量 (YAP/TAZ 的 同源物)靶基因表达的变化。我们揭示了 YAP/TAZ 抑制剂的延长寿命作用,这主要与 和 基因表达水平的降低有关。然而,需要进一步的分析来理解 YAP/TAZ 途径与衰老之间的联系。